Comparable safety and non-inferior immunogenicity of the SARS-CoV-2 mRNA vaccine candidate PTX-COVID19-B and BNT162b2 in a phase 2 randomized, observer-blinded study
在一项 2 期随机、观察者盲法研究中,SARS-CoV-2 mRNA 候选疫苗 PTX-COVID19-B 和 BNT162b2 具有相当的安全性和不劣于 BNT162b2 的免疫原性。
期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-024-55320-1
Reiter, Lawrence; Greffrath, Johann; Zidel, Bian; Ostrowski, Mario; Gommerman, Jennifer; Madhi, Shabir A; Tran, Richard; Martin-Orozco, Natalia; Panicker, Rajesh Krishnan Gopalakrishna; Cooper, Curtis; Pastrak, Aleksandra